Innovation of Iglarlexi in Intensification
Prof. Abdulrahman Al Sheikh, consultant endocrinology and diabetes, presenting the first head-to-head comparison of iGlarLixi and premix insulin.
MAT-BH-2200601/v1/August 2022
This website is intended exclusively for healthcare professionals residing and/or working in Oman.
Prof. Abdulrahman Al Sheikh, consultant endocrinology and diabetes, presenting the first head-to-head comparison of iGlarLixi and premix insulin.
MAT-BH-2200601/v1/August 2022
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.